TOKYO] Strategists at Goldman Sachs cut their targets for key Chinese stock indexes for a second time this month, citing ...

The US may have to change its strategy thanks to Chinese firm DeepSeek’s AI, which looks promising for the future of the ...

The hitch in decision making has caused a growing backlog of deals at Goldman Sachs, he said ... trading during the market swings around DeepSeek's impact on Nvidia Corp. (NVDA) as well as ...

A potential U.S. launch of this Chinese biotech's new lung cancer drug - which bested Merck's blockbuster Keytruda - is a key ...

Goldman Sachs has once again lowered its targets for major Chinese stock indexes, citing growing trade tensions between the U ...

The MSCI China Index rose as much as 2.5% Monday, as investors enjoyed some respite after the US announced a pause in tariffs ...